A system of pharmacovigilance is created and operates in the company in order to control the safety and efficacy of medicines use, the main objective of which is identification, assessment and timely prevention of adverse reactions, adverse events or other problems associated with the use of pharmaceutical preparations of the company, as well as providing information to the competent government agencies.

In order to monitor adverse reactions of drugs a special “report card” form is developed for the registration of adverse reactions in accordance with international requirements and recommendations.

Extreme cases of adverse reactions may be reported on the hotline.

The hot line:

Tel:                 (+ 37493) 47 74 68

                         (+ 37494) 66 06 17

                         (+ 37460) 37 88 11